title: [Vulvovaginitis: correlation with predisposing factors, clinical manifestations and microbiological studies].
abstract: Vaginitis (V) and bacterial vaginosis (BV) are one of the most common reasons the middle class patient has to consult a gynaecologist. The purpose of this work is to analyse samples of vaginal fluid targeting the infection etiology and its relationship to related factors: (intrauterine devices, contraceptive pills, condoms, use of antibiotics), symptoms and signs. From November 1, 2001 to October 30, 2003, a cross-section study was carried out of 400 nonpregnant, sexually active women in an age range of 15 to 55. Vaginal secretions were analysed by Gram and Giemsa stains and culturing was used. Interpreting: (1) normal--no observable changes, absence of the infecting agents studied here; (2) infected--changes observed: bacterial vaginosis, vaginal candidiasis (CV) and trichomoniasis (TC) and (3) imbalance in vagina ecology, with medium alterations (D). Results obtained: (1) normal: 209 (52.2%); infected: 115 (28.8%) including 13.5% VB, 12.5% CV, 2.8% TC, and (3) 76 (19%) with imbalance of vagina ecology. Bacterial vaginosis and flora imbalance were related to the use of intrauterine devices, and candidiasis to contraceptive pills and previous antibiotic use. The number of symptoms increased in patients with vaginal candidiasis and trichomoniasis.
authors: Division Bacteriología, Laboratorio CEDIBI, Sanatorio NOSTI, Avda. Mitre 325 (2300) Rafaela, Pcia. de Santa Fe, Argentina. sonialab@arnet.com.ar
authors: S
authors: S
authors: Fosch
authors: N
authors: N
authors: Fogolín
authors: E
authors: E
authors: Azzaroni
authors: N
authors: N
authors: Pairetti
authors: L
authors: L
authors: Dana
authors: H
authors: H
authors: Minacori
authors: I
authors: I
authors: Tita
authors: M
authors: M
authors: Redona
authors: G
authors: G
authors: Gribaudo
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001118:Argentina / Q000453:epidemiology; D001826:Body Fluids / Q000382:microbiology; D002181:Candidiasis, Vulvovaginal / Q000453:epidemiology / Q000382:microbiology; D017280:Condoms / Q000009:adverse effects; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D007434:Intrauterine Devices / Q000009:adverse effects; D008875:Middle Aged; D012307:Risk Factors; D014247:Trichomonas Vaginitis / Q000453:epidemiology / Q000382:microbiology; D014621:Vagina / Q000382:microbiology; D016585:Vaginosis, Bacterial / Q000453:epidemiology* / Q000382:microbiology; D014848:Vulvovaginitis / Q000453:epidemiology* / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D003278:Contraceptives, Oral, Hormonal